RCM
TECH icon

Radnor Capital Management’s Bio-Techne TECH Stock Holding History

Radnor Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,890
Closed -$360K – 326
2026
Q1 		$360K Sell
6,890
-11,975
-63% -$719K 0.05% 255
2025
Q4 		$1.11M Buy
+18,865
New +$1.15M 0.16% 146
2024
Q4 		– Sell
-2,645
Closed -$211K – 335
2024
Q3 		$211K Buy
+2,645
New +$199K 0.03% 320
2022
Q4 		– Sell
-6,752
Closed -$479K – 245
2022
Q3 		$479K Hold
6,752
– – 0.14% 159
2022
Q2 		$585K Hold
6,752
– – 0.16% 148
2022
Q1 		$731K Buy
6,752
+972
+17% +$100K 0.18% 142
2021
Q4 		$748K Buy
5,780
+2,120
+58% +$260K 0.18% 130
2021
Q3 		$443K Hold
3,660
– – 0.26% 59
2021
Q2 		$412K Sell
3,660
-1,580
-30% -$166K 0.14% 133
2021
Q1 		$500K Buy
5,240
+60
+1% +$5.47K 0.16% 132
2020
Q4 		$411K Buy
5,180
+60
+1% +$4.34K 0.12% 151
2020
Q3 		$317K Buy
5,120
+240
+5% +$15.6K 0.11% 155
2020
Q2 		$325K Buy
+4,880
New +$292K 0.12% 138

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Radnor Capital Management's TECH Position: Q2 2026 in Review

Radnor Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 6,890 shares — an estimated $360K sold.

Radnor Capital Management first reported a position in TECH in Q2 2020 and held it in 13 quarters. The position peaked at $1.11M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Radnor Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Radnor Capital Management sold 6,890 Bio-Techne shares in Q2 2026, an estimated $360K.
  • Radnor Capital Management first reported a position in Bio-Techne in Q2 2020 and held it in 13 quarters.
  • Radnor Capital Management's Bio-Techne position peaked at $1.11M in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.